Simplex Trading
STOK icon

Simplex Trading’s Stoke Therapeutics STOK Stock Holding History

Simplex Trading’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,600
Closed -$305K – 10109
2025
Q4 		$305K Buy
9,600
+7,600
+380% +$228K ﹤0.01% 3794
2025
Q3 		$47K Sell
2,000
-500
-20% -$8.57K ﹤0.01% 6525
2025
Q2 		$28K Sell
2,500
-1,100
-31% -$10.4K ﹤0.01% 6480
2025
Q1 		$23K Buy
3,600
+3,100
+620% +$28.9K ﹤0.01% 6480
2024
Q4 		$5K Sell
500
-500
-50% -$6.14K ﹤0.01% 7659
2024
Q3 		$12K Sell
1,000
-800
-44% -$11.3K ﹤0.01% 7090
2024
Q2 		$24K Sell
1,800
-30,000
-94% -$405K ﹤0.01% 6747
2024
Q1 		$429K Buy
+31,800
New +$193K ﹤0.01% 3999
2023
Q4 		– Sell
-9,600
Closed -$37K – 9787
2023
Q3 		$37K Sell
9,600
-1,300
-12% -$8.55K ﹤0.01% 6078
2023
Q2 		$115K Buy
10,900
+10,200
+1,457% +$109K ﹤0.01% 4911
2023
Q1 		$5K Buy
+700
New +$6.32K ﹤0.01% 8080
2021
Q2 		– Sell
-3
Closed -$11K – 10684
2021
Q1 		$11K Sell
3
-19
-86% -$1.08K ﹤0.01% 7852
2020
Q4 		$136K Buy
22
+3
+16% +$138 ﹤0.01% 5106
2020
Q3 		$63K Sell
19
-3
-14% -$86 ﹤0.01% 5393
2020
Q2 		$52K Buy
+22
New +$522 ﹤0.01% 5461

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Simplex Trading's STOK Position: Q1 2026 in Review

Simplex Trading reduced its Stoke Therapeutics (STOK) stake by 99% in Q1 2026, selling an estimated $464K and leaving 130 shares worth $4.23K. The position accounts for ﹤0.01% of the portfolio, ranked #7998.

Simplex Trading first reported a position in STOK in Q1 2020 and has held it in 18 quarters since. The position peaked at $537K in Q2 2023. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • Simplex Trading held 130 shares of Stoke Therapeutics worth $4.23K as of Q1 2026.
  • Simplex Trading sold 14,151 Stoke Therapeutics shares in Q1 2026, an estimated $464K.
  • Stoke Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7998 holding.
  • Simplex Trading first reported a position in Stoke Therapeutics in Q1 2020 and has held it in 18 quarters since.
  • Simplex Trading's Stoke Therapeutics position peaked at $537K in Q2 2023.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.